Ahmed M. Al‐Abd
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents 11
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 8
- Molecular Medicine top 5%
- Pharmacology top 2%
- Ginger and Zingiberaceae research 7
-
- Nigella sativa pharmacological applications 6
-
- Cancer, Lipids, and Metabolism 8
-
- Drug Transport and Resistance Mechanisms 7
- Metal complexes synthesis and properties 6
-
- Natural product bioactivities and synthesis 7
- Co-authors
- Ali M. El‐HalawanyAshraf B. Abdel‐NaimHossam M. AbdallahVladimir P. TorchilinTarek A. AhmedKhalid M. El‐SayHossam S. El‐SawyRiham Salah El-Dine
- Partner nations
- EgyptSaudi ArabiaUnited Arab Emirates
In The Last Decade
Ahmed M. Al‐Abd
82 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Toxicology 215
- Biomaterials 579
- Molecular Medicine 144
- Pharmacology 241
- Complementary and alternative medicine 214
Countries citing papers authored by Ahmed M. Al‐Abd
This map shows the geographic impact of Ahmed M. Al‐Abd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed M. Al‐Abd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed M. Al‐Abd more than expected).
Fields of papers citing papers by Ahmed M. Al‐Abd
This network shows the impact of papers produced by Ahmed M. Al‐Abd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed M. Al‐Abd. The network helps show where Ahmed M. Al‐Abd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ahmed M. Al‐Abd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 13 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 33 | |
| 8 | 2021 | 5 | |
| 9 | 2020 | 45 | |
| 10 | 2019 | 74 | |
| 11 | 2018 | 38 | |
| 12 | 2017 | 158 | |
| 13 | 2016 | 10 | |
| 14 | 2015 | 11 | |
| 15 | 2014 | 33 | |
| 16 | 2011 | 33 | |
| 17 | 2011 | 18 | |
| 18 | 2009 | 111 | |
| 19 | 2008 | 43 | |
| 20 | 2007 | 1 |
About Ahmed M. Al‐Abd
Ahmed M. Al‐Abd is a scholar working on Toxicology, Applied Microbiology and Biotechnology and Pharmacology, having authored 86 papers that have together received 3.0k indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (11 papers), Nanoparticle-Based Drug Delivery (8 papers), Cancer, Lipids, and Metabolism (8 papers), Drug Transport and Resistance Mechanisms (7 papers), Ginger and Zingiberaceae research (7 papers), Natural product bioactivities and synthesis (7 papers), Metal complexes synthesis and properties (6 papers) and Nigella sativa pharmacological applications (6 papers). The work is most often cited by research in Toxicology (215 citations), Biomaterials (579 citations) and Molecular Medicine (144 citations). Ahmed M. Al‐Abd has collaborated with scholars based in Egypt, Saudi Arabia and United Arab Emirates. Frequent co-authors include Ali M. El‐Halawany, Ashraf B. Abdel‐Naim, Hossam M. Abdallah, Vladimir P. Torchilin, Tarek A. Ahmed, Khalid M. El‐Say, Hossam S. El‐Sawy, Riham Salah El-Dine, Fahad A. Al‐Abbasi and Hyo‐Jeong Kuh.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.